NEW YORK, NY / ACCESSWIRE / June 14, 2016 / Clean Coal Technologies, Inc. (OTC: CCTC) (“CCTI” or the “Company”), a cleaner-energy company utilizing patented technology to convert raw coal into a cleaner burning and more efficient fuel, today announced that they will hold a webcast on Thursday, June 23, 2016 to update the market on significant developments as the technology moves closer to playing a leading role in sustaining coal as a major force in providing power to the global power markets.

“Management will update the markets on successful strategic meetings with the US Government, State governors / legislatures and domestic and international coal and power companies including one of the largest Chinese Coal and Power companies,” said Robin Eves President and CEO, adding that, “we will also update the market on the progress in designing and engineering the first commercial modules.”

“It is a long and tough road from a successful test plant to the design, engineering and successful building of a commercial plant but we now have incredible support both domestically and internationally and are on course to have the first major technology successfully deployed around the world,” concluded Mr. Eves.

Details of the webcast will be posted on the company website in the coming days on www.cleancoaltechnologiesinc.com.

About Clean Coal Technologies, Inc.

Clean Coal Technologies, Inc., a cleaner-energy technology company with headquarters in New York City, NY, holds patented process technology and other intellectual property that converts raw coal into a cleaner burning fuel. The Company’s trademarked end products, “Pristine™” coals, are significantly more efficient, less polluting, more cost-effective, and provide more heat than untreated coal. The principal elements of the Company’s pre-combustion technology are based on well-proven science and tried-and-tested industrial components. The Company’s clean coal technology may reduce some 90% of chemical pollutants from coal, including Sulfur and Mercury, thereby resolving emissions issues affecting coal-fired power plants. For more information about Clean Coal Technologies please visit: www.cleancoaltechnologiesinc.com.

Forward Looking Statements

This release may include forward-looking statements related to CCTI’s plans, beliefs and goals, which involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Such statements include, but are not limited to, statements about CCTI’s plans, objectives, expectations and intentions with respect to future operations, its products, its ability to secure financing for its operations, the impact on the industry and other statements identified by words such as “will,” “potential,” “could,” “can,” “believe,” “intends,” “continue,” “plans,” “expects,” “anticipates,” “estimates,” “may,” and other words of similar meaning or the use of future dates. Additional details about CCTI’s business and its operations that could affect CCTI’s actual results are described in CCTI’s filings with the Securities and Exchange Commission, including the “Risk Factors” that are part of its most recent annual report on Form 10-K for the year ended December 31, 2015 and in each of its subsequently filed periodic reports. All forward-looking statements in this release speak only as of the date of this news release. CCTI undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

For More information please contact:

Sean Mahoney, Media consultant: seamah@gmail.com

SOURCE: Clean Coal Technologies, Inc.

ReleaseID: 441129

LOS ANGELES, CA / ACCESSWIRE / June 14, 2016 / Green Cures & Botanical Distribution Inc. (OTC Pink: GRCU) today is excited to announce the company’s renewed strength and focus towards executing its business model throughout the end of the year.

GRCU has been diligently focused on its vertically integrated business model by taking advantage of the exploding cannabis and hemp industry. There are three key areas of our business model rapidly moving forward.

The first is the launch of our skin care line in which (GRCU) develops, produces and distributes premium hemp based products in the following categories: Skin Care, Beauty, Fashion and lifestyle goods branded under the Original Hollywood Hemp™ brand. These products can now been viewed on our newly launched website www.originalhollywoodhemp.com and will be available for purchase and distribution in the summer of 2016.

In 2016, the global skincare market is estimated to be worth about USD 121 billion. In 2017, this figure is expected to jump to $127 billion, in 2018 it will increase to $133 billion, in 2019 it will increase further to $140 billion, in 2020 it will be $147 billion and in 2021 it will reach $154 billion (Source: Statista)

The second facet to our revenue producing model will be our beverage division. GRCU will utilize all natural ingredients, some of the beverage line will include hemp infused ingredients, both bringing a fresh an innovative product to market. Additionally, these beverages will be branded with internationally known famous sports stars and rock legends to position itself in a manner to leverage its celebrity branded beverages produced through its ICONIC Beverages Collection.

The third is the acquisition. Green Cures & Botanical Distribution Inc. is currently working to acquire additional products as well. Currently, management is in negotiations with a nationally known skin care company who has a strong footprint in the health and wellbeing of skincare.

Joe Tragesser, Green Cures & Botanical Distribution Inc. CEO states, “We have been purposefully working to acquire and negotiate partnerships which will aid in GRCU’s growth and stability. I am very excited about the opportunities GRCU has been presented with as we have been working very hard towards achieving our goals and taking our company to the next level.” Mr. Tragesser further stated, “Our top priorities are to accelerate the company’s performance and advance GRCU’s evolution to expand business partnerships and make strategic decisions that enhance GRCU’s potential. We will continue to keep all shareholders informed of all activity that is taking place.”

ABOUT GREEN CURES & BOTANICAL DISTRIBUTION INC.

Green Cures & Botanical Distribution Inc., is a development stage company that wholesales and retails hemp-infused nutritional, botanical, sports, and body care products. The company is currently Web-based and focuses on online retailing. Green Cures & Botanical Distribution Inc., operates a diverse portfolio of products and services within the botanical and cannabis industry, as permitted by law. From concept to production and distribution, Green Cures & Botanical Distribution Inc., is continuously creating and introducing products that promote a healthy lifestyle. Icon Beverages will make up the beverage division of GRCU which will feature celebrity iconic notables who are recognized worldwide.

SAFE HARBOR ACT

Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:

info@instepholdingsllc.com

SOURCE: Green Cures & Botanical Distribution Inc.

ReleaseID: 441110

SCOTTSDALE, AZ / ACCESSWIRE / June 14, 2016 / Talia Jevan Properties, Inc., a private real estate operating company, in partnership with Mr. Colin Scarlett from Colliers International, is proud to announce that it won the 2016 NAIOP and Business in Vancouver, BC Commercial Real Estate Award of Excellence in the Office Lease category at a recent awards gala.

The Office Lease Award of Excellence acknowledges innovation and creativity in meeting the objectives of both the landlord and tenant. Talia Jevan Properties was recognized for its lease with Global Relay, a cloud technology company that provides archiving and information governance solutions for electronic communications. Global Relay has been a long-term, valued tenant of Talia Jevan at its Gastown property located at 220 Cambie Street, better known as the Leckie Building.

Global Relay’s office lease is the largest in Gastown history. Vancouver’s original downtown, Gastown, was named fourth most stylish neighborhood in the world in 2012 by Complex, a New York fashion magazine. It is currently home to many boutique fashion shops, design and furniture stores, popular restaurants, and professional and technology companies. Global Relay is the only tenant in Vancouver to expand in the same building more than 10 times – starting with 2,500 square feet of space in 2005 and increasing to 62,000 square feet today.

“By providing Global Relay with a high quality building in a premier location – in a place they’re proud to call home – we’re gratified to play a small role in their ongoing success as one of BC’s most awarded technology companies,” said Harmel S. Rayat, President of Talia Jevan Properties, Inc. “Our tenants regard our properties as valuable tools to attract and retain quality staff, proudly host their clients, and generate healthy profits over time. We are committed to treating every tenant the same way a luxury five-star hotelier would treat their guests – with respect and courtesy.”

Leckie building, Global Relay corporate headquarters located at 220 Cambie St., Vancouver, BC (Gastown)

Every two years, NAIOP and Business in Vancouver recognize the industry’s best based on their performance, innovation, creativity, teamwork, collaboration, and community and environmental awareness. Real estate is critical to ensuring a business has a place to grow. According to Global Relay, their relationship with their landlord, Talia Jevan Properties, has allowed them to develop and prosper while servicing more than 20,000 customers in 90 countries around the world.

“Because of our business friendly partnership with our landlord, we have been able to expand our business globally from one of the world’s most beautiful cities, in one of Western Canada’s most accommodating, attractive, and well-serviced buildings,” said Kelvin Ng, Director of Business Operations at Global Relay. “Mr. Rayat has made it possible for us to expand our office space when we needed to, ensuring we can continue to grow.”

Due to its ‘tenant-first’ approach, Talia Jevan’s in-house portfolio of approximately 500,000 square feet of properties enjoys aggregate occupancy rates of 95% or better. For the 10-year period ending 2015, Talia Jevan’s portfolio has appreciated 326% (33% annualized). This growth is especially impressive when compared to just 6% for the S&P 500 and 9% for the FSTE NAREIT All Index over the same period.

About
Talia Jevan Properties, Inc.:

Talia Jevan Properties, Inc. (“Talia Jevan”) is a private real estate operating company specializing in the acquisition and long-term ownership of premium commercial real estate assets in cities with economic strength, growth potential, social and cultural diversity, and geographical appeal.

Beginning with an equity investment of just $20 million in 2006, Talia Jevan has successfully implemented a disciplined investment strategy to acquire commercial properties that have generated superior returns while providing significant capital appreciation. As of December 31, 2015, Talia Jevan’s in-house portfolio was independently appraised at almost $150 million, generating an annualized equity growth of 33%, as compared to just 6% for the S&P 500 and 9% for the FSTE NAREIT All Index over the same period.

Based on the success of its in-house portfolio, Talia Jevan is sponsoring the Talia Jevan Realty Fund I, LLLP (“Fund”), which seeks to provide accredited investors a relatively low-risk high rate of return while providing for capital appreciation through the acquisition and eventual resale of premium high-quality properties.

To learn more about the Fund and to receive its offering materials, click here or call 800-214-7792.

Media
Contact:

TrendLogic
Dwain Schenck
800-992-6299
dwain@trendlogicpr.com

DISCLAIMER: This press release is for general information purposes only and does not discuss the risks associated with real estate investments. The historical results of operations set forth in this press release are those of Talia Jevan Properties, Inc., and not Talia Jevan Realty Fund I, LLLP (Fund). Past performance is not an indication of future results and no assurances can be given that the Fund will achieve similar results to those of Talia Jevan Properties, Inc. There exists a risk of loss. This is neither an offer to sell nor a solicitation of an offer to buy any security, which can be made only by a Confidential Private Placement Memorandum (PPM) dated February 1, 2016, as it may be amended from time to time. Talia Jevan Properties, Inc. and Talia Jevan Realty Fund I, LLLP, make no representations as to the suitability for any purpose of any investment whatsoever. Securities offered will only be offered by the officers and directors of the general partners of the Fund in accordance with and pursuant to available exemptions from the registration requirements of applicable securities laws. All statements made and description of documents referred to herein are qualified in their entirety by reference to the PPM.

SOURCE: Talia Jevan Properties, Inc.

ReleaseID: 441084

Dear Daycare Parent Comforts Busy Parents with Practical Advice

NEWINGTON, CT / ACCESSWIRE / June 14, 2016 / The authors of Dear Daycare Parent: The Must-have Guide to Daycare for Working Parents, recognized an information gap in the parenting book market. Parents could learn all about different teaching philosophies or get guidance on how to raise their kids, but no one was talking to them about how to handle the daycare experience: until now.

Jo-Ann Parylak and Jackie Rioux, co-authors of Dear Daycare Parent, set about creating a practical resource for new parents. The book details all aspects of a typical daycare or preschool day and arms parents with the information they need to make the experience the best it can be for themselves and their child.

The book contains over 101 tips, each with a key point, a detailed description of why it is important, and is augmented with a real-life example. Illustrations throughout, along with an occasional story of how a situation was handled, complement the text and drive home the value of the information being shared.

This colorful and often humorous book, published in February of this year, has garnered critical acclaim from several publishing industry reviewers. Notably, Library Journal, the leading library trade journal issued a starred review in May with a positive verdict, calling the book “upbeat” and recommending it “for all libraries.”

Rioux, who came up with the idea, says, “It’s hard enough balancing work-life and parenthood. Daycare adds a whole new wrinkle into the mix. If you’re a new parent and you’re starting your child in daycare, this is the manual you need. It tells you everything you need to know to make the transition as easy as possible. It helps you achieve that work-life balance a little bit faster and with a lot less anxiety.”

Both authors have a combined 45 years of experience in all aspects of daycare, including starting and running preschool programs from scratch. Rioux and Parylak both worked at the former world-famous Newington Children’s Hospital daycare and preschool program for many years.

Dear Daycare Parent is available at libraries, leading book retailers, and online from Amazon.com or direct from the publisher at www.DearDaycareParent.com.

For more information on Dear Daycare Parent, please visit: http://www.deardaycareparent.com.

SOURCE: Dear Daycare Parent

ReleaseID: 441094

Could this Acquisition turn out to be a game changer for both companies

LONDON, UK / ACCESSWIRE / June 14, 2016 / ActiveWallSt.com announces its coverage of the Technology Sector with focus on the Tech giant Microsoft Corp. (NYSE: MSFT) as the company came out with one of the biggest M&A deals in the technology space in recent times. Microsoft has proposed to acquisition LinkedIn (NYSE: LNKD) with the deal likely to be scrutinized by regulators even more thoroughly than several such acquisitions given the vastly different business growth trajectories of both companies. Register with us now for your free membership at:

http://www.activewallst.com/register/

Today, ActiveWallSt.com is promoting its Tech sector coverage with emphasis on MSFT. Get all of our research for free by signing up to http://www.activewallst.com/register/.

Looking at the deal’s numbers indicates that Microsoft is putting great faith in LinkedIn’s potential.

Deal offers some staggering numbers on display…

The deal value of US$26.2 billion implies a share price of US$196 per LinkedIn share, and is at a massive 64% premium to LinkedIn’s Friday, June 10’s close. With LinkedIn still incurring losses, the deal values the company at 25-26x FY2016 adjusted EBITDA guidance of US$985–1,005 million. The deal, which would be funded by cash, is nearly 25% of Microsoft’s total cash and short-term investments of US$106 billion (as of March 2016), and nearly 7% of the company’s market capitalization of US$393 billion.

…nevertheless, focus should be on long-term synergies

While the numbers appear staggering despite the acquiring company in question being Microsoft, a buyout of this nature and scale needs to be looked beyond the immediate math. Microsoft, under the new leadership of Satya Nadella, appears to be taking a big strategic bet. Enterprise remains Microsoft’s key element for its growth strategy with cloud-based enterprise services are also fast becoming an integral part of this strategy. LinkedIn, with over 430 million users (a meaningful percentage of that is corporate subscriptions), offers Microsoft a big leap in the enterprise social platform space over the cloud. Microsoft would attempt to bring as many of LinkedIn’s users on its platforms and cross-sell a suite of products and services.

Not the first, but definitely the most defining decisions in social networking

This is not Microsoft’s first inorganic foray into the social networking space. In 2012, the company acquired Yammer, a social platform for enterprises, for US$1.2 bn. While it was among the first investors in Facebook (NYSE: FB), the company’s attempts to participate in the cloud-based social platform spectrum have largely revolved around solutions built for enterprises rather than individual consumers. Especially since Microsoft’s share in the personal computing operating system market has come off due to growing acceptance of Google’s Android and Apple’s iOS, the focus has been on enterprise solutions – products and services.

Acquisition calls for patience among Microsoft’s long-term holders

It would appear to many that the likes of Google (NYSE: GOOG), Facebook, and Apple (NYE: APPL) are likely to dominate the technology space across personal computing, operating system, cloud services for enterprises and consumers.

Microsoft’s acquisition of LinkedIn would perhaps require some views to be revisited. Given Microsoft’s stagnating business performance and a strategy focused on buy-backs and dividends, the acquisition could change the way competition and enterprises would consider it in future. LinkedIn, on the other hand, could dip into Microsoft’s reserves for much larger organic and inorganic initiatives combining with the former’s superior enterprise software skills. An acquisition as big and strategic as this would require investors to exercise patience and look for longer-term strategic results vis-à-vis immediate short-term financial gains.

Technicals

LinkedIn stocks jumped 46.64% closing at $192.21, on Monday June 13, 2016, post the acquisition announcement. Until the deal news, LinkedIn’s stock had tanked 41.76% since the beginning of the year. Microsoft’s share went down 2.60% closing at $50.14 for Monday’s trading session. Microsoft’s shares are down 9.63% since the beginning of 2016.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:
Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom
Email: info@activewallst.com
Phone number: 1-858-257-3144

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 441125

LONDON, UK / ACCESSWIRE / June 14, 2016 / ActiveWallSt.com announces the list of stocks for today’s research coverage. Pre-market the Active Wall St. team provides the latest corporate, market and technical events impacting selected stocks on the Healthcare Information Services industry. Companies recently under review include Cerner, Veeva Systems, WebMD Health, and Inovalon. Register with us now for your free membership and see our complete reports on these equities at:

http://www.activewallst.com/register/

Today, ActiveWallSt.com is promoting its equity research coverage. Get all of our research report free by signing up to http://www.activewallst.com/register/.

The demand for healthcare information and systems is on the rise, and given the broad range of products and services that the Healthcare Information Services industry covers, competition is very stiff. Let us see how this is affecting some of the big names in the industry. Register for our free insights and research reports on these stocks today:

http://www.activewallst.com/register/

ActiveWallSt.com looks at how each of the aforementioned companies have fared over the last few trading sessions.

Cerner Corp. (NASDAQ: CERN)

Shares in North Kansas City, Missouri headquartered Cerner Corp. ended Monday’s session at $55.72, gaining 0.20%. The stock recorded a trading volume of 1.25 million shares. The Company’s shares have advanced 2.31% in the last one month and 4.54% in the previous three months. The stock is trading 0.14% below its 50-day moving average. Moreover, shares of Cerner, which designs, develops, markets, installs, hosts, and supports health care information technology, health care devices, hardware, and content solutions for health care organizations and consumers in the U.S. and globally, have a Relative Strength Index (RSI) of 51.23.

Veeva Systems Inc. (NYSE: VEEV)

Pleasanton, California headquartered Veeva Systems Inc.’s stock climbed 0.29%, closing the day at $34.15. A total volume of 1.70 million shares was traded, which was above their three months average volume of 1.31 million shares. The Company’s shares have advanced 24.68% in the last month, 28.19% in the previous three months, and 18.37% since the start of this year. The stock is trading 19.77% above its 50-day moving average and 29.98% above its 200-day moving average. Additionally, shares of Veeva Systems, which provides industry cloud software and data solutions for the life sciences industry, have an RSI of 73.96.

WebMD Health Corp. (NASDAQ: WBMD)

On Monday, shares in New York headquartered health information services provider, WebMD Health Corp. recorded a trading volume of 473,569 shares, and ended the day 0.91% lower at $62.33. The stock has gained 7.11% in the previous three months and 29.05% on an YTD basis. The Company’s shares are trading above their 200-day moving average by 21.32%. Furthermore, shares of WebMD Health have an RSI of 40.43.

Inovalon Holdings Inc. (NASDAQ: INOV)

Bowie, Maryland headquartered technology Company, Inovalon Holdings Inc.’s stock saw a correction of 2.27%, finishing yesterday’s session at $17.26 and with a total volume of 407,363 shares traded. The Company’s shares have advanced 3.11% in the last one month and 1.53% since the start of this year. The stock is trading below its 50-day moving average by 4.35%. Additionally, shares of Inovalon Holdings, which provides cloud-based data analytics and data-driven intervention platforms to the healthcare industry in the U.S., have an RSI of 37.48.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:
Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom
Email: info@activewallst.com
Phone number: 1-858-257-3144

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 441121

LONDON, UK / ACCESSWIRE / June 14, 2016 / ActiveWallSt.com announces the list of stocks for today’s research coverage. Pre-market the Active Wall St. team provides the latest corporate, market and technical events impacting selected stocks on the Drug Manufacturers-Other industry. Companies recently under review include Ionis Pharma, Depomed, Amarin, and United Therapeutics. Register with us now for your free membership and see our complete reports on these equities at:

http://www.activewallst.com/register/

Today, ActiveWallSt.com is promoting its equity research coverage. Get all of our research report free by signing up to http://www.activewallst.com/register/.

Despite emerging competitors and pricing pressures, a number of stocks in the Drug Manufacturers industry remains unscathed and are even signaling growth. Let us see how the market environment is impacting some of the big names in the industry. Access our market analysis and much more today by signing up at:

http://www.activewallst.com/register/

Let us take a brief technical look at how each of the companies mentioned above have fared over the last few trading sessions.

Ionis Pharmaceuticals Inc. (NASDAQ: IONS)

On Monday, shares in Carlsbad, California headquartered RNA-targeted drug discovery and development Company, Ionis Pharmaceuticals Inc., recorded a trading volume of 2.27 million shares. The stock ended the day at $21.47, which was a correction of 1.29%. The Company’s shares are trading below their 50-day moving average by 38.62%. Furthermore, Ionis Pharmaceuticals’ stock has a Relative Strength Index (RSI) of 29.09. On May 27th, 2016, research firm Needham reiterated its ‘Buy’ rating with a decrease of the target price to $55 a share from $88 a share for the Company’s stock.

Depomed Inc. (NASDAQ: DEPO)

Newark, California headquartered specialty pharmaceutical Company, Depomed Inc.’s stock finished yesterday’s session 1.26% lower at $19.57 and with a total volume of 823,778 shares traded. The Company’s shares have gained 11.70% in the last one month, 20.50% over the previous three months, and 7.94% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 9.38% and 6.39%, respectively. Furthermore, shares of Depomed, which engages in the development, sale, and licensing of products for pain and other central nervous system conditions in the U.S., have an RSI of 52.48. On May 27th, 2016, research firm Mizuho reiterated its ‘Buy’ rating with an increase of the target price to $23 a share from $19 a share for the Company’s stock.

Amarin Corp. PLC (NASDAQ: AMRN)

At the closing bell on Monday, shares in Dublin, Ireland-based biopharmaceutical Company, Amarin Corp. PLC gained 0.47%, ending the day at $2.13. The stock recorded a trading volume of 1.06 million shares, which was higher than its three months average volume of 984,490 shares. The Company’s shares have advanced 37.42% in the last one month, 30.67% in the previous three months, and 12.70% since the start of this year. The stock is trading 17.07% above its 50-day moving average and 17.16% above its 200-day moving average. Moreover, shares of Amarin, which focuses on the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the U.S., have an RSI of 61.46.

United Therapeutics Corp. (NASDAQ: UTHR)

Silver Spring, Maryland headquartered biotechnology Company, United Therapeutics Corp.’s stock ended the day 1.16% lower at $110.06 and with a total volume of 564,568 shares traded. The Company’s shares have gained 0.76% in the last month. The stock is trading 3.17% below its 50-day moving average. Additionally, shares of United Therapeutics, which develops and commercializes products to address the unmet medical needs of patients with chronic and life-threatening diseases globally, have an RSI of 40.65.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:
Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom
Email: info@activewallst.com
Phone number: 1-858-257-3144

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 441123